Physician profile
Kimberley Hunt
NPI 1790788412
$3,953.04
in general payments reported to CMS, 2019-2025
19 companies · $326 in 2025
The $326 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $218 · 2021: $269 · 2022: $184 · 2023: $2,306 · 2024: $305 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,130 · Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,129.66 |
| Food and Beverage | $806.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,129.66 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $679.65 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $214.82 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ucb, INC. | $182.89 | 2021-2025 | Nayzilam, Briviact |
| Tris Pharma INC | $162.55 | 2019-2021 | |
| Corium, LLC | $112.66 | 2024-2025 | Azstarys |
| Pfizer INC. | $93.44 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.94 | 2020-2022 | |
| Sanofi Pasteur INC. | $57.90 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $45.02 | 2019 | |
| Astellas Pharma US INC | $40.59 | 2019 | |
| Genzyme Corporation | $38.33 | 2022 | |
| Abbvie INC. | $38.30 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $22.15 | 2025 | Neffy |
| Seqirus USA INC | $14.66 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.52 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.26 | 2021 | |
| Shire North American Group INC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberley Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.